Contineum Therapeutics (CTNM) Total Current Liabilities (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Total Current Liabilities of $6.5 million for Q2 2026, down 9.54% year-over-year from $7.2 million in Q2 2025, and down 1.97% quarter-over-quarter from $6.7 million in Q1 2026.
Contineum Therapeutics (CTNM) Total Current Liabilities (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Total Current Liabilities history runs 4 years deep, the most recent figure standing at $6.5 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 9.54% year-over-year to $6.5 million; the TTM figure through Jun 2026 stood at $6.5 million (down 9.54% YoY), while the FY2025 annual figure was $9.7 million, down 2.31% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $6.5 million, down from $6.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $10.0 million in Q4 2024, with the low at $3.7 million in Q2 2024.
- The 4-year median for Total Current Liabilities is $6.5 million (2026), against an average of $7.0 million.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities surged 92.94% in 2025, then dropped 25.61% in 2026.
- Contineum Therapeutics' Total Current Liabilities stood at $5.5 million in 2023, then surged by 81.87% to $10.0 million in 2024, then declined by 2.31% to $9.7 million in 2025, then plunged by 33.03% to $6.5 million in 2026.
- Business Quant data shows CTNM's Total Current Liabilities at $6.5 million in Q2 2026, $6.7 million in Q1 2026, and $9.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 6.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.53 Mn |
| Mar 31, 2026 | 6.66 Mn |
| Dec 31, 2025 | 9.74 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 7.21 Mn |
| Mar 31, 2025 | 8.95 Mn |
| Dec 31, 2024 | 9.97 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 6.23 Mn |
| Dec 31, 2023 | 5.48 Mn |